Advertisement

Topics

BRIEF—Relugolix hits endpoint in Phase III trial in pain associated with uterine fibroids

10:40 EST 10 Nov 2017 | thePharmaLetter

Positive top-line results have been reported from a Phase III trial of relugolix for the treatment of…

Original Article: BRIEF—Relugolix hits endpoint in Phase III trial in pain associated with uterine fibroids

NEXT ARTICLE

More From BioPortfolio on "BRIEF—Relugolix hits endpoint in Phase III trial in pain associated with uterine fibroids"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...